Atlas Trials

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

Clinical trial NCT03720613 · RECRUITING

Trial details

NCT number
NCT03720613
Sponsor
BioDelivery Sciences International
Status
RECRUITING
Study type
OBSERVATIONAL
Opioid-induced Constipation
Start date
2019-01-04
Primary completion
2030-11-01
Enrollment
34532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.